According to the data in Table 3, age, race, marital status, grade, tumor size, T stage, N stage, surgery, chemotherapy, radiation therapy, receiving radiation treatment, surgery and chemotherapy treatments, CA125, bone metastasis, brain metastasis, liver metastasis, and lung metastasis were potential predictors for 2-year overall survival of patients with metastatic ovarian cancer. The gene discussed is MUC16; the disease is bone metastasis.